Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds

Journal of Clinical Microbiology

Volumn 37, Issue 5, 1999, Pages 1480-1483

  Szekely, Adrien ^a   Johnson, Elizabeth M ^a,b   Warnock, David W ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE;

ABSIDIA; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; CONTROLLED STUDY; DILUTION; EXOPHIALA; FUSARIUM; IN VITRO STUDY; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; MYCOLOGY; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY;

ABSIDIA; ABSIDIA CORYMBIFERA; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; EXOPHIALA; EXOPHIALA DERMATITIDIS; FUSARIUM; FUSARIUM SOLANI; PSEUDALLESCHERIA BOYDII; SCEDOSPORIUM PROLIFICANS; SCOPULARIOPSIS BREVICAULIS;

EID: 0032944880     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.5.1480-1483.1999     Document Type: Article

References (24)

1. Anaissie, E. 1992. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin. Infect. Dis. 14(Suppl. 1):S43-S53.
2. Berenguer, J., J. L. Rodriguez-Tudela, C. Richard, M. Alvarez, M. A. Sanz, L. Gaztelurrutia, J. Ayats, J. V. Martinez-Suarez, and the Scedosporium prolificans Spanish Study Group. 1997. Deep infections caused by Scedosporium prolificans: a report on 16 cases in Spain and a review of the literature. Medicine 76:255-265.
3. Chen, S. C. A., M. L. O'Donnell, S. Gordon, and G. L. Gilbert. 1996. Antifungal susceptibility testing using the Etest: comparison with the broth macrodilution technique. J. Antimicrob. Chemother. 37:265-273.
4. Colombo, A. L., F. Barchiesi, D. A. McGough, and M. G. Rinaldi. 1995. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J. Clin. Microbiol. 33:535-540.
5. Colombo, A. L., F. Barchiesi, D. A. McGough, A. W. Fothergill, and M. G. Rinaldi. 1995. Evaluation of the Etest system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole. J. Antimicrob. Chemother. 36:93-100.
6. Denning, D. W., S. A. Radford, K. L. Oakley, L. Hall, E. M. Johnson, and D. W. Warnock. 1997. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J. Antimicrob. Chemother. 40:401-414.
7. Denning, D. W., K. Venkateswarlu, K. L. Oakley, M. J. Anderson, N. J. Manning, D. A. Stevens, D. W. Warnock, and S. L. Kelly. 1997. Itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 41:1364-1368.
8. Espinel-Ingroff, A. 1994. E test for antifungal susceptibility testing of yeasts. Diagn. Microbiol. Infect. Dis. 19:217-220.
9. Espinel-Ingroff, A., M. Bartlett, R. Bowden, N. X. Chin, C. Cooper, A. Fothergill, M. R. McGinnis, P. Menezes, S. A. Messer, P. W. Nelson, F. C. Odds, L. Pasarell, J. Peter, M. A. Pfaller, J. H. Rex, M. G. Rinaldi, G. S. Shankland, T. J. Walsh, and I. Weitzman. 1997. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J. Clin. Microbiol. 35:139-143.
10. Espinel-Ingroff, A., K. Dawson, M. Pfaller, E. Anaissie, B. Breslin, D. Dixon, A. Fothergill, V. Paetznick, J. Peter, M. Rinaldi, and T. Walsh. 1995. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Artimicrob. Agents Chemother. 39:314-319.
11. Gamis, A. S., T. Gudnason, G. S. Giebink, and N. K. C. Ramsay. 1991. Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev. Infect. Dis. 13:1077-1088.
12. Lass-Florl, C., G. Kofler, G. Kropshofer, J. Hermans, A. Kreczy, M. P. Dierich, and D. Niederwieser. 1998. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J. Antimicrob. Chemother. 42:497-502.
13. Lozano-Chiu, M., P. W. Nelson, M. Lancaster, M. A. Pfaller, and J. H. Rex. 1997. Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B. J. Clin. Microbiol. 35:270-272.
14. Morrison, V. A., R. J. Haake, and D. J. Weisdorf. 1994. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. Am. J. Med. 96:497-503.
15. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. Document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. Odds, F. C., F. Van Gerven, A. Espinel-Ingroff, M. S. Bartlett, M. A. Ghannoum, M. V. Lancaster, M. A. Pfaller, J. H. Rex, M. G. Rinaldi, and T. J. Walsh. 1998. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob. Agents Chemother. 42:282-288.
17. Pujol, I., J. Guarro, J. Gene, and J. Sala. 1997. In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains. J. Antimicrob. Chemother. 39:163-167.
18. Rex, J. H., C. R. Cooper, Jr., W. G. Merz, J. N. Galgiani, and E. J. Anaissie. 1995. Detection of amphotericin B-resistant Candida isolates in a brothbased system. Antimicrob. Agents Chemother. 39:906-909.
19. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, and A. Barry for the Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itracunazole and candida infections. Clin. Infect. Dis. 24:235-247.
20. Sewell, D. L., M. A. Pfaller, and A. L. Barry. 1994. Comparison of broth macrodilution, broth microdilution, and Etest antifungal susceptibility tests for fluconazole. J. Clin. Microbiol. 32:2099-2102.
21. Vanden Bossche, H., D. W. Warnock, B. Dupont, D. Kerridge, S. Sen Gupta, L. Improvisi, P. Marichal, F. C. Odds, F. Prevost, and O. Ronin. 1994. Mechanisms and clinical impact of antifungal drug resistance. J. Med. Vet. Mycol. 32(Suppl. 1):189-202.
22. Vartivarian, S. E., E. J. Anaissie, and G. P. Bodey. 1993. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin. Infect. Dis. 17(Suppl. 2):S487-S491.
23. Walsh, T. J., J. Peter, D. A. McGough, A. W. Fothergill, M. G. Rinaldi, and P. A. Pizzo. 1995. Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrob. Agents Chemother. 39:1361-1364.
24. Wanger, A., K. Mills, P. W. Nelson, and J. H. Rex. 1995. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob. Agents Chemother. 39:2520-2522.